The War on Cancer

An Anatomy of Failure, a Blueprint for the Future

(Autor)

Buch | Softcover
227 Seiten
2008 | 2005 ed.
Springer-Verlag New York Inc.
978-1-4020-8620-5 (ISBN)

Lese- und Medienproben

The War on Cancer - Guy B. Faguet
21,39 inkl. MwSt
  • Titel ist leider vergriffen;
    keine Neuauflage
  • Artikel merken
This book shows that, contrary to frequent announcements of breakthroughs, our current cancer control model cannot eradicate most cancers and details the reasons why. It then identifies how this can be changed.
After reviewing the history of cancer and its impact on the population, Dr. Faguet exposes the antiquated notions that have driven cancer drug development, documents the stagnation in treatment outcomes despite major advances in cancer genomics and growing NCI budgets, and identifies the multiple factors that sustain the status quo. He shows that, contrary to frequent announcements of breakthroughs, our current cancer control model cannot eradicate most cancers and the reasons why. Significantly, this book also delineates a way forward via a shift from the discredited cell-kill approach of the past to an integrated, evidence-driven cancer control paradigm based on prevention, early diagnosis, and pharmacogenomics. The author's views are based on data published in mainstream scientific journals and other reliable references, 432 of which are cited.

Introduction Part I Cancer Statistics: Some Facts Chapter 1 Assessing the magnitude of the problem Chapter 2 The problem is growing, not going away Part II What Is Cancer? Chapter 3 Cancer through the ages Chapter 4 Our current understanding Part III How Is Cancer Treated? Chapter 5 The cancer-cell kill paradigm: Hypotheses and corollaries Chapter 6 Chemotherapy drugs Chapter 7 Treatment outcomes: Dismal by any standard Part IV Why Does This System Persist? Chapter 8 The role of the National Cancer Institute Chapter 9 Publications: The facts and nothing but the facts? Chapter 10 From the doctors' perspective Chapter 11 From the patients' perspective Part V Where Do We Go From Here? Chapter 12 A vision for the future Chapter 13 Shifting from the cell-kill paradigm to molecular therapies

Erscheint lt. Verlag 3.6.2008
Zusatzinfo biography
Verlagsort New York, NY
Sprache englisch
Maße 156 x 234 mm
Gewicht 348 g
Themenwelt Medizin / Pharmazie Allgemeines / Lexika
Medizin / Pharmazie Gesundheitswesen
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Studium 1. Studienabschnitt (Vorklinik) Physiologie
Studium Querschnittsbereiche Epidemiologie / Med. Biometrie
ISBN-10 1-4020-8620-2 / 1402086202
ISBN-13 978-1-4020-8620-5 / 9781402086205
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hans-Christian Pape; Armin Kurtz; Stefan Silbernagl

Buch (2023)
Thieme (Verlag)
110,00

von Stefan Gründer; Klaus-Dieter Schlüter

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
69,00